Other
Prediabetes
1
Pipeline Programs↗
16
Active Trials↗
5
Companies Involved↗
PreDiabetes is an early-stage landscape with 1 program across 5 companies. The most active players are Eli Lilly, Astellas, Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 21
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
43
clinical trials
Completed23 · 53%
Not yet recruiting8 · 19%
Recruiting8 · 19%
Unknown status3 · 7%
Withdrawn1 · 2%
Clinical Trials
Trial Activity
43 trials
Mechanisms for Activation of Beige Adipose Tissue in Humans
Recruiting·—·Phase 2·NCT04666636·65 enrolled
Effects of Avocado on Triglyceride Metabolism in Individuals With Insulin Resistance
Recruiting·Clinical Nutrition Research Center, Illinois Institute of Technology·Preclinical·NCT07624500·82 enrolled
Reversal to Normoglycemia by Treating Prediabetes
Not yet recruiting·—·Phase 3·NCT07392151·158 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)